Colleen Sakon

6PUBLICATIONS
2CO-AUTHORS
Social epidemiologyPacific Peoples theory of change models for healthPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 28, 2022
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.

Colleen Sakon, Miley Nikirk, Andrew Ross Wickman O'Brien

|Dec 09, 2022
A survey assessing the impact of COVID-19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis.

Colleen Sakon, Hilary Vogt, Cynthia D Brown

|Nov 02, 2022
Opportunity for pharmacogenetics testing in patients with sickle cell anemia.

Katherine A Gallaway, Colleen Sakon, Jefney Ongeri

|Jun 07, 2022
Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosis.

Colleen M Sakon, Emma M Tillman

|Dec 30, 2021
Opportunity for pharmacogenomic testing in patients with cystic fibrosis.

Colleen Sakon, Leah A Alicea, Heather Patacca

|Mar 14, 2020
Neurotoxicity in adult patients with cystic fibrosis using polymyxin B for acute pulmonary exacerbations.

Nick Rekis, Madelaine Ambrose, Colleen Sakon

Pageof 1

Frequent Collaborators

4 joint publications

Emma M Tillman

1 joint publications

Katherine A Gallaway